Sort
78,016 grants matching “breast cancer”
Transplant Models
$1,211,872Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Epidemiologic Field Studies
$1,211,800Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
$1,211,647Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,211,401Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
RANDOMIZED TRIAL OF BREAST SELF EXAMINATION IN SHANGHAI
$1,211,250Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Studies of Occupational Cancer
$1,210,861Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
FUNCTIONAL MECHANISM AND TARGETING OF METADHERIN IN BREAST CANCER
$1,210,740The Trustees Of Princeton University · · FY2016 · Department of the Army
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
$1,210,404Raymond Nelson Dubois · University Of Tx Md Anderson Can Ctr · U54 · FY2011 · CA
Physical Activity, Energy Balance, and Cancer
$1,210,218Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Environmental Exposure and DNA Damage
$1,209,937Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
$1,209,609Nathan J McDannold · Brigham And Women'S Hospital · P01 · FY2017 · CA
Methods for Etiologic Studies of Diet and Cancer
$1,209,555Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Implementation, Adoption, and Utility of Family History in Diverse Care Settings
$1,209,455Geoffrey S Ginsburg · Duke University · U01 · FY2017 · HG
Nuclear receptors: action, functions, and roles in disease
$1,209,453Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Breast Cancer Risk and Molecular Change After Chernobyl
$1,208,872Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Overcoming Barriers to Effective Care for Minorities
$1,208,054Mount Sinai School Of Medicine Of Nyu · P60 · FY2005 · MD
SBIR Phase II: High throughput and antigen specific T-cell receptor discovery for solid tumor treatments
$1,207,999Binbin Chen · Vcreate, Inc. · · FY2024 · TIP
PROMINENT - UCSF
$1,207,862Allan Balmain · University Of California, San Francisco · OT2 · FY2023 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$1,207,854Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
CCR-Frederick Flow Cytometry Core
$1,207,572Kathleen Noer · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Bastyr/UW Oncomycology Translational Research Center
$1,207,565Leanna J Standish · Bastyr University · U19 · FY2012 · AT
Signaling Pathways in Stage of Mammary Tumorigenesis
$1,207,211Boston University Medical Campus · P01 · FY2003 · ES
Overcoming Barriers to Effective Care for Minorities
$1,207,068Mark R Chassin · Icahn School Of Medicine At Mount Sinai · P60 · FY2006 · MD
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8461 UNDER
$1,206,941Daniel Sullivan · H. Lee Moffitt Cancer Ctr & Res Inst · N01 · FY2009 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain
$1,206,858Jing Wang · New York University School Of Medicine · UH3 · FY2023 · CA